Log In
BCIQ
Print this Print this
 

inebilizumab (MEDI-551)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionAnti-CD19 mAb
Molecular Target CD19
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today